2008: Cytokines, Mediators, and Gene Regulation II
Search or Browse by Day

Cytokines, Mediators, and Gene Regulation II

Tuesday, October 28, 2008
1325
The Expression of MicroRNA-424 in Rheumatoid Arthritis
1326
TWEAK Stimulation of Resident Kidney Cells in the Pathogenesis of Nephritis in a Murine Lupus Model
1327
IL-17A Expression Is Modulated by Biologic Therapy And Drives Inflammatory Cell Migration In The Human RA Joint
1328
Expression Of Mdc/ccl22 And Its Receptor Ccr4 In Rheumatoid Arthritis And Psoriatic Arthritis
1329
A Potential Role For TNF-Like Weak Inducer of Apoptosis (TWEAK) in the Pathogenesis of Lupus Nephritis
1330
The effect of Wnt signaling in rheumatoid arthritis fibroblsast-like synoviocytes
1331
Th1 and Th17 Balance in Inflammatory Myopathies: Interaction with Dendritic Cells and Link with Response to a Treatment with High-dose Intravenous Immunoglobulins
1332
Collagen Type II And Aggrecan Expression In Human OA Chondrocytes Submitted To RNAi For Hypoxia Inducible Factor-1 Alpha (HIF-1α) Gene
1333
Expression and Functional Role of the C-class Chemokine Lymphotactin (XCL1) in Wegener`s Granulomatosis
1334
Increased expression of IL-22 and IL-22BP in Rheumatoid Arthritis and Spondyloarthropathies
1335
Loss of TGF-ß Signaling in Dendritic Cells Results in Autoimmune Pancreatitis
1336
Etanercept Impairs Maturation of Human Monocyte-Derived Dendritic Cells by Inhibiting the Autocrine TNFα-Mediated Signaling
1337
Regulation Of IL-17 Responses By CTLA-4Ig
1338
In Vitro Properties Of CAM-3001, A Human Anti GM-CSF Receptor Antibody For The Treatment Of Patients With Rheumatoid Arthritis
1339
Use Of A SOCS3 Ex-vivo Pharmacodynamic Quantitative RT-PCR Assay For CAM-3001, A New Antibody Therapy For The Treatment Of Rheumatoid Arthritis
1340
Neutralizing IFN-α In SLE Affects GM-CSF, TNF-α, IL-10, IL1-β And BAFF Signaling Pathways
1341
Modulation Of IL-18BPa Production By RA Synovial Fibroblasts: Results Of Cytokine Profiling
1342
Rituximab Reduces Levels of Autoantibodies to Cytokines and Formation of Autoantibody/Cytokine Immune Complexes in Patients with Rheumatoid Arthritis
1343
Angiopoeitin2 Predicts Clinical Response to Anti-TNFα Therapy and Sensitizes Synovial Tissue to the Effect of TNFα in the Arthritic Joint
1344
IL-2 Is The Mediator Of NKT Cell That Breaks T Cell Anergy And Induces Rheumatoid Factor (RF) After Repeated Immunization With Exogenous Antigen
1346
IFN-α/β as a Therapeutic Target In SLE, Myositis, and RA: A Transcript Profiling Analysis Of Whole Blood From Several Autoimmune Diseases
1347
Microbial Factors Differentially Induce IL-1 Production in "CIAS1 Mutation Positive and Negative" Patients with Neonatal-Onset Multisystem Inflammatory Disease (NOMID)
1348
IFN-a Effects on Expression of Fusion-Related Molecules in Osteoclast Precursors: Insights into Non-Erosive SLE Arthropathy
1349
DNA from RA Patients Shows Different Methylation Levels at the TNF Promoter Compared to Controls
1350
Inhibition Of anti-CD28 Induced 150kDa Adenosine Deaminase That Acts On RNA (ADAR1) Gene Expression By Inositol Hexakisphosphate (IP6) In Normal T Lymphocytes
1351
The Effects Of Adiponectin On Osteoarthritic Chondrocytes
1352
Direct Osteoclastogenic Potential of Proinflammatory Cytokines-TNFα, IL-1, IL-6, IL-17 and IL-23
1353
Effects Of TNFα, IL-1, And IL-17 On Osteoblast Differentiation Of Human Bone Marrow-derived Mesenchymal Stem Cells
1354
Differential Effects of TNF Blockers on TB-induced Gene Expression
1355
Histone Deacetylase Inhibitors Suppress Interleukin-1β Induced mPGES-1 Expression In Human Chondrocytes
1356
IFN/TNF Cross-Regulation in vivo during Infliximab Treatment in Rheumatoid Arthritis
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>